期刊文献+

Ca^(2+)/calpain信号调控纤连蛋白诱导的MCF-10A乳腺上皮细胞-间质转化的作用

Fibronectin induced epithelial-mesenchymal transition of MCF-10A mammary epithelial cells regulated by Ca^(2+)/calpain signaling
原文传递
导出
摘要 目的:观察Ca^(2+)/calpain信号通路在纤连蛋白(FN)诱导MCF-10A乳腺上皮细胞-间质转化(EMT)中的作用。方法:以正常培养MCF-10A乳腺上皮细胞为实验对象。采用比色法检测细胞内Ca^(2+)浓度;采用荧光分光光度法检测钙蛋白酶-2(calpain-2)活性;Western blot法检测calpain-2、波形蛋白(vimentin)、E-钙黏着蛋白(E-cadherin)的表达;采用划痕修复实验检测细胞迁移能力;Transwell小室实验检测细胞侵袭能力。结果:FN诱导MCF-10A细胞中Ca^(2+)浓度、calpain-2活性表达明显升高,上调vimentin、calpain-2蛋白表达,下调E-cadherin蛋白水平;FN诱导MCF-10A细胞迁移和侵袭能力显著增强。钙离子螯合剂(BAPTA-AM)和氨氯地平(amlodipine)均能显著抑制FN诱导的细胞Ca^(2+)浓度、calpain-2活性及表达升高;抑制vimentin蛋白表达上调及E-cadherin蛋白表达下调;抑制FN诱导MCF-10A细胞迁移和侵袭能力增强。结论:BAPTA-AM和Amlodipine均能够抑制FN诱导的上皮间质转化。FN能够诱导MCF-10A乳腺上皮细胞发生EMT,可能与Ca^(2+)/calpain信号通路激活有关。 OBJECTIVE To investigate the regulatory effects of Ca^(2+)/calpain signaling pathway on epithelial-mesenchymal transition of MCF-10 A mammary epithelial cells induced by fibronectin(FN).METHODS The MCF-10 A mammary epithelial cells were cultured in the present experiments.The cell Ca^(2+)concentration was detected by colorimetric assay.The activity of calpain-2 was measured by fluorescence spectrophotometry.Vimentin,E-cadherin and calpain-2 protein were determined by Western blot.Cell migration was measured by wound healing assay,and invasion was determined by transwell chamber assay.RESULTS BAPTA-AM and amlodipine significantly inhibited the Ca^(2+)and calpain-2 expression in cells induced by FN,and FN could up-regulate vimentin expression and down-regulate E-cadherin expression.The FN-induced MCF-10 Acell migration and invasion were inhibited by BAPTA-AM and amlodipine.CONCLUSION The present results show that both BAPTA-AM and amlodipine can inhibit FN-induced epithelia transformation and the mechanism may involve in Ca^(2+)/calpain signaling pathway activation.
作者 陈林 洪端阳 陈宗跃 潘迪 付凌云 王婧 樊双琴 沈祥春 陈妍 CHEN Lin;HONG Duan-yang;CHEN ZONG-yue;PAN Di;FU Ling-yun;WANG Jing;FAN Shuang-qin;SHEN Xiang-chun;CHEN Yan(Guizhou Medical University, Guizhou Guiyang 550025, China;The High Educational Key Laboratory of Guizhou Province for Natural Medicinal Pharmacology and Druggability, Guizhou Guiyang 550025, China)
出处 《中国医院药学杂志》 CAS 北大核心 2018年第6期599-603,共5页 Chinese Journal of Hospital Pharmacy
基金 国家自然科学基金资助项目(编号:81560598 81302804) 中国博士后基金(编号:2015M582759XB) 贵阳市科技局项目(编号:筑科合同[20141001]) 贵州省教育厅自然科学基金优秀人才计划(编号:黔教合KY字[2015]492) 贵州省科学技术基金(编号:黔科合J字[2014]2007号) 2016年度高层次创新型人才计划"千层次"(编号:71000305) 贵州2016年大学生创新创业训练计划项目(编号:201610660042) 贵州省高等教育科技创新团队(编号:黔教合人才团队字[2014]31) 贵州省科技创新团队(编号:黔科合人才团队[2015]4025号) 贵州省高层次创新型人才百层次人才(编号:贵州省科技厅黔科合人才[2015]4029号) 贵州医科大学开放性实验(编号:070701817)
关键词 钙离子螯合剂 氨氯地平 MCF-10A乳腺上皮细胞 纤连蛋白 上皮间质转化 BAPTA-AM amlodipine MCF-10A mammary epithelial cells fibronectin epithelial-mesenehyrnal transformation
  • 相关文献

参考文献7

二级参考文献50

共引文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部